Updated October 1, 2026.
Decentralized crowdfunding for science is not a single standardized product category. In practice, current platforms use several different mechanisms: public research proposals, token-based incentives, community governance, IP-linked funding, and donor-supported scientific bounties. Researchers should distinguish these models before choosing where to raise money.
ResearchHub
ResearchHub provides a direct path for scientific proposals and requests for proposals. Researchers can submit proposals for open review, while funders can support research through the platform. ResearchHub also uses ResearchCoin for bounties and incentives around peer review, replication, discussion, and other scientific contributions.
Useful when: you want a public, research-specific funding mechanism with open discussion and proposal review.
VitaDAO
VitaDAO funds longevity and biotechnology research through community and token-enabled structures. Its published portfolio includes IP-NFT, equity, and initiative funding.
Useful when: the project is specifically in longevity or related biotechnology and the team is comfortable with intellectual-property, governance, and commercialization structures that may be more complex than ordinary crowdfunding.
Molecule
Molecule provides infrastructure for funding and tokenizing scientific intellectual property. Its IP-NFT and Science IP Token models are designed to connect research financing with IP governance and commercialization.
Useful when: the project has potentially valuable intellectual property and is considering a structured DeSci financing model rather than a simple donation campaign.
Traditional crowdfunding can still be appropriate
Not every scientific project needs a token or DAO. For small experiments, fieldwork, equipment, open-source research software, or public-interest research, conventional donation or crowdfunding platforms may be simpler. The important questions are whether the platform permits the proposed use of funds, what fees apply, how donors are protected, what reporting is expected, and whether the researcher can legally receive the funds.
Questions to answer before choosing a platform
- What exactly is being funded? A defined experiment, a researcher, a company, a research program, or intellectual property?
- What does the funder receive? Nothing beyond supporting the work, a governance token, a bounty, equity, IP-linked rights, or another claim?
- Who controls the money? The researcher, an institution, a DAO, a nonprofit, or a smart contract?
- How is scientific quality assessed? Open review, expert review, token voting, AI assistance, or no formal review?
- What happens if the experiment fails? Scientific failure can still produce useful knowledge, but the platform should be clear about reporting and unused funds.
- What legal restrictions apply? Token sales, equity, cross-border fundraising, tax treatment, and securities law can materially change the answer.
Science DAO and AIIM
Science DAO’s AI Internet-Meritocracy (AIIM) takes a different approach. It is an experimental system designed to allocate donated funds to researchers and open-source contributors using AI-assisted evaluation of documented contributions. It is not presented as an investment or equity-crowdfunding platform.
The next proposed milestone is a five-month adversarial test with a public fundraising target of $1,300: $1,000 for eligible recipient distributions and $300 for AI, hosting, and related operating costs. See the test proposal, evidence hub, and transparency records.
Practical conclusion
ResearchHub is the clearest fit in this list for proposal-oriented scientific crowdfunding and open research incentives. VitaDAO is much more specialized toward longevity biotechnology. Molecule is primarily relevant where scientific IP and commercialization are central. Researchers should choose based on the funding relationship they actually need rather than selecting a platform merely because it uses blockchain.
Disclosure: Science DAO operates in the DeSci ecosystem. This article is informational and does not constitute financial, legal, tax, or investment advice.
Help Turn AIIM’s Beta into Evidence
AIIM remains experimental. The next proposed milestone is a five-month public adversarial test, with $1,000 planned for distribution to eligible funding recipients. Donations support the work required to run and evaluate that test.
Fund the public test → Test proposal → Independent review →
AI-generated evaluations can contain factual errors or biases; decentralized governance and non-custodial components remain under development. Public testing, auditability, and external criticism remain part of the project.